Pipeline Power — Inside AbbVie's $90B+ Drug Development Engine

AbbVie has more than 90 drug and device programs in active development across immunology, oncology, neuroscience, eye care, and aesthetics — supported by 14,000 R&D staff across six centers of excellence in the U.S., Germany, and Japan. This module gives candidates the pipeline literacy to reference real programs by name, understand AbbVie's therapeutic strategy, and answer "what do you know about our science?" with substance.